Paclitaxel Articles
DELIVER trial misses endpoint; Guidant merger with Cook off
6 January 2003
Angiotech increases losses
19 August 2002
High-dose Xyotax to be tested in GOG trial
19 August 2002
Guilford posts $16.8M loss in 2nd quarter
19 August 2002
Cell Thera initiates Ph III Xyotax trial
5 August 2002
B-MS turnover down 14% in 2nd quarter
29 July 2002
Phyton expands paclitaxel deal with B-MS
15 July 2002
Boston Sci raises equity in Natural Pharma
15 July 2002
NaPro dealt blow on EU paclitaxel patent
8 July 2002
Bioscience to market Dabur products
24 June 2002
Cell Therapeutics refines Xyotax trial protocal
17 June 2002
B-MS sued over Taxol protection attempts
10 June 2002
Herceptin disappoints in lung cancer
3 June 2002
Taxol vs Taxotere trial finds tox advantage
3 June 2002
New data on Ligand's Targretin, Ontak
27 May 2002
BioNumerik/Grelan chemoprotectant
27 May 2002
Alimta: first effective mesothelioma drug
27 May 2002
Xenova says lead drug on track for Phase III
20 May 2002
Cook starts new paclitaxel stent trial in EU
20 May 2002
Stock Commentary - New York
13 May 2002
Abbott, NaPro get OK for generic Taxol in USA
13 May 2002
New trial of Kosan's epothilone D in cancer
6 May 2002
Lilly starts pivotal trial of antisense NSCLC drug
29 April 2002
Sonus reports progress with paclitaxel
15 April 2002
Bristol-Myers Squibb issues profit warning for 2002
15 April 2002
Boston Sci gets OK for TAXUS IV stent trial
1 April 2002
Stock Commentary - New York
1 April 2002
Bristol-Myers Squibb slumps as Vanlev data disappoints
25 March 2002
UK's NICE gives backing to Roche's Herceptin
25 March 2002
Biocompatibles stent fails in pivotal trials
18 March 2002
NeoPharm's SS1-PE38 an orphan drug, says FDA
25 February 2002
InterMune starts Ph III ovarian cancer trial
11 February 2002
Guidant files Achieve stent in Europe
11 February 2002
IVAX' paclitaxel gets ok to stay on US market
4 February 2002
Angiotech drug-eluting stent: zero restenosis
28 January 2002
Antisoma drug boosts activity of taxanes
28 January 2002
Sonus raises $13.6 million
28 January 2002
IVAX welcomes Ca court decision on AB Taxol-related patents.
21 January 2002
Tally of NCEs in 2001 lends credence to talk of R&D productivity
21 January 2002
Isis says Phase III trial complete for LY900003.
21 January 2002
US FTC probes Orange Book patent listings
14 January 2002
World bulk paclitaxel market study
7 January 2002
World bulk paclitaxel market study
21 December 2001
US states file BuSpar lawsuit against B-MS
13 December 2001
FDA grants GPC Biotech orphan status for bryostatin-1
13 December 2001
Angiotech cleared to extend paclitaxel trial in MS
29 November 2001
Stock Commentary - New York
22 November 2001
B-MS sued in cancer drug pricing case
22 November 2001
Bristol-Myers Squibb highlights five key products at R&D day
15 November 2001
Stock Commentary - New York
8 November 2001
ISIS 3521 news
8 November 2001
Protarga's Taxoprexin in Ph II prostate study
6 November 2001
IVAX profits leap, but Onxol disappoints
29 October 2001
Genentech boosted by Avastin study
26 October 2001
Tokyo stock comment; week to October 22
24 October 2001
B-MS earnings driven by Glucophage
24 October 2001
Chugai in $73M deal with Cell Therapeutics
23 October 2001
IVAX reports progress with oral paclitaxel
23 October 2001
American Pharmaceutical files IPO
5 October 2001
Stock Commentary - New York
4 October 2001
Stock Commentary - New York
27 September 2001
Boston Sci claims zero restenosis with stent
26 September 2001
Ribozyme begins third Angiozyme trial
26 September 2001
New NICE guidance on Fludara in CLL; breast cancer advice on taxanes to
25 September 2001
Boston Sci claims zero restenosis with stent
25 September 2001
Bristol-Myers Squibb taking stake in ImClone for $1 billion
20 September 2001
Bristol-Myers Squibb to take stake in ImClone for $1 billion?
19 September 2001
Cook's paclitaxel-coated stent eliminates restenosis
13 September 2001
IVAX' oral paclitaxel shows promise in Ph II
6 August 2001
Stock Commentary - New York
2 August 2001
Stock Commentary - New York
1 August 2001
Stock Commentary - New York
26 July 2001
NaPro wins Euro patent ruling on paclitaxel
12 July 2001
Stock Commentary - New York
14 June 2001
Trials begin for Protarga's cancer drug
8 June 2001
Cell Therapeutics to sell $150 mill in notes
7 June 2001
US consumer groups pledge more lawsuits
15 May 2001
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
